Apurva Shah
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Apurva Shah has a total of 24 co-authors. Here are the top co-authors by number of shared publications:
Shravan Bohra
Medical Gastroenterology and Hepatology Department, Apollo Hospitals International Limited, India
7 shared publicationsDeepak Amarapurkar
Department of Gastroenterology and Hepatology, Bombay Hospital and Medical Research Center, Mumbai, India
3 shared publicationsDeepak N. Amarapurkar
Department of Gastroenterology, Bombay Hospital & Medical Research Center, Mumbai, India
2 shared publicationsAstha M. Mulani
Department of Obstetrics and Gynaecology, Bombay Hospital and Medical Research Institute, Mumbai, India
1 shared publicationDeepak N Amarapurkar
1 shared publication- Madhuri Chandnani
Bombay Hospital and Medical Research Center
1 shared publication
Latest Publications
- Open Access
- 12 November 2026
- Published by Georg Thieme Verlag KG in Journal of Digestive Endoscopy
Percutaneous Endoscopic Gastrostomy: Preferred Mode of Mid- and Long-Term Enteral Access Yet Underutilized in India
Percutaneous endoscopic gastrostomy (PEG) is the preferred mode for establishing long-term enteral feeding worldwide. This review provides an overview of current indications, contraindications, techniques, complications, and postprocedure care related to PEG placement, with an emphasis on Indian practice. Post-PEG placement management and care by relatives/caretakers with PEG removal methods are also emphasized in the article. Though PEG placement is associated with minor or even major complications, the majority of patients do well if we follow standard practices as mentioned in the article. Informal estimates from selected tertiary centers and industry sources suggest that PEG utilization in India may be significantly lower than expected; however, the lack of a national registry limits precise measurement. Factors accounting for this are lack of awareness and acceptance by patients/relatives, lack of counseling from treating physician/surgeon, cost involved and even unawareness, and poor acceptance in the doctor community due to prevalent misconceptions.
- 12 November 2026
- Published by Georg Thieme Verlag KG in Journal of Digestive Endoscopy
Open AccessPercutaneous Endoscopic Gastrostomy: Preferred Mode of Mid- and Long-Term Enteral Access Yet Underutilized in India
Percutaneous endoscopic gastrostomy (PEG) is the preferred mode for establishing long-term enteral feeding worldwide. This review provides an overview of current indications, contraindications, techniques, complications, and postprocedure care related to PEG placement, with an emphasis on Indian practice. Post-PEG placement management and care by relatives/caretakers with PEG removal methods are also emphasized in the article. Though PEG placement is associated with minor or even major complications, the majority of patients do well if we follow standard practices as mentioned in the article. Informal estimates from selected tertiary centers and industry sources suggest that PEG utilization in India may be significantly lower than expected; however, the lack of a national registry limits precise measurement. Factors accounting for this are lack of awareness and acceptance by patients/relatives, lack of counseling from treating physician/surgeon, cost involved and even unawareness, and poor acceptance in the doctor community due to prevalent misconceptions.
- 11 November 2020
- Published by Springer Nature in Indian Journal of Gastroenterology
- Vol. 40 (1) , 35-40
Argon plasma coagulation—an effective treatment for solitary rectal ulcer syndrome: A single-center experience from western India
Background and Aim Solitary rectal ulcer syndrome (SRUS) is an uncommon benign disorder of defecation. Management of ulcers is usually unsatisfactory with conventional treatment (laxatives, behavioral therapy, biofeedback, topical treatments, and surgery). Studies on the effectiveness of argon plasma coagulation (APC) for SRUS refractory to conventional treatment is lacking. The aim of the study was to examine the effect of APC with conventional therapy in controlling bleeding and healing of refractory SRUS. Methods Fourteen patients of refractory SRUS diagnosed on clinical, colonoscopic, and histological findings, refractory to conventional therapy, were offered multiple sessions of APC in addition to conventional treatment. All patients were followed up to determine bleeding control and ulcer healing. Results Fourteen patients with a mean duration of symptoms of 9.21 ± 6.94 months were included. All the patients were advised to have a high intake of fluids and laxatives and to undergo biofeedback in addition to the APC. Lesions were located anteriorly (66%), circumferentially (25%), and posteriorly (9%). Mean follow-up duration was 7 months (3 to 12 months). APC enabled bleeding control in all the patients (100%), complete healing of ulcer in 71% (10 patients), and reduction in ulcer size to less than 50% of the initial size in the remaining 29% patients. None of the patients had any procedure-related complications like bowel perforation, infections, or fistula formation. Conclusions APC with conventional therapy is effective in controlling bleeding and healing in SRUS refractory to conventional treatment.
- 11 November 2020
- Published by Springer Nature in Indian Journal of Gastroenterology
- Vol. 40 (1) , 35-40
Argon plasma coagulation—an effective treatment for solitary rectal ulcer syndrome: A single-center experience from western India
Background and Aim Solitary rectal ulcer syndrome (SRUS) is an uncommon benign disorder of defecation. Management of ulcers is usually unsatisfactory with conventional treatment (laxatives, behavioral therapy, biofeedback, topical treatments, and surgery). Studies on the effectiveness of argon plasma coagulation (APC) for SRUS refractory to conventional treatment is lacking. The aim of the study was to examine the effect of APC with conventional therapy in controlling bleeding and healing of refractory SRUS. Methods Fourteen patients of refractory SRUS diagnosed on clinical, colonoscopic, and histological findings, refractory to conventional therapy, were offered multiple sessions of APC in addition to conventional treatment. All patients were followed up to determine bleeding control and ulcer healing. Results Fourteen patients with a mean duration of symptoms of 9.21 ± 6.94 months were included. All the patients were advised to have a high intake of fluids and laxatives and to undergo biofeedback in addition to the APC. Lesions were located anteriorly (66%), circumferentially (25%), and posteriorly (9%). Mean follow-up duration was 7 months (3 to 12 months). APC enabled bleeding control in all the patients (100%), complete healing of ulcer in 71% (10 patients), and reduction in ulcer size to less than 50% of the initial size in the remaining 29% patients. None of the patients had any procedure-related complications like bowel perforation, infections, or fistula formation. Conclusions APC with conventional therapy is effective in controlling bleeding and healing in SRUS refractory to conventional treatment.
- Open Access
- 1 June 2019
- Published by SAGE Publications in Apollo Medicine
- Vol. 16 (2) , 100-102
Cervical Esophageal Perforation during Gastroscopy in Adults:Case Report - Report of Two Cases
Cervical esophageal perforation is rare and associated with a high morbidity and mortality >20% if misdiagnosed. At least half of the perforations are iatrogenic, mostly related to endoscopic instrumentation used in the upper gastrointestinal tract. We describe two cases of cervical esophageal perforations during negotiating the cricopharynx. Both patients had malignant stricture in mid and lower esophagus, respectively, and developed iatrogenic perforation during palliative metallic stenting – one of the two by a pediatric gastroscope. Both the patients were diagnosed as having esophageal perforation in the first 6 h after procedure and successfully managed with medical management. Patients with small perforations and minimal extraesophageal involvement may be managed with nonoperative treatment.
- 1 June 2019
- Published by SAGE Publications in Apollo Medicine
- Vol. 16 (2) , 100-102
Open AccessCervical Esophageal Perforation during Gastroscopy in Adults:Case Report - Report of Two Cases
Cervical esophageal perforation is rare and associated with a high morbidity and mortality >20% if misdiagnosed. At least half of the perforations are iatrogenic, mostly related to endoscopic instrumentation used in the upper gastrointestinal tract. We describe two cases of cervical esophageal perforations during negotiating the cricopharynx. Both patients had malignant stricture in mid and lower esophagus, respectively, and developed iatrogenic perforation during palliative metallic stenting – one of the two by a pediatric gastroscope. Both the patients were diagnosed as having esophageal perforation in the first 6 h after procedure and successfully managed with medical management. Patients with small perforations and minimal extraesophageal involvement may be managed with nonoperative treatment.
- Open Access
- 1 April 2019
- Published by Georg Thieme Verlag KG in Journal of Digestive Endoscopy
- Vol. 10 (2) , 97-100
Sedation and Anesthesia in Gastrointestinal Endoscopy: Indian Scenario
Sedation in endoscopy is a drug-induced depression in the level of consciousness. Traditionally, the sedation regime most commonly used for conscious sedation during gastrointestinal (GI) endoscopy was a combination of opioids and benzodiazepines. However, in the last two decades, propofol is regarded as the sine qua non agent for gastroenterological endoscopic sedation. A thorough risk evaluation before the procedure and monitoring during the procedure are paramount. In elective endoscopy, unplanned adverse events are rare, occurring in 1.4% of procedures. All currently available guidelines state that the endoscopist is not permitted to administer propofol and to monitor the patient. This task must be done by an additional person, who has the sole responsibility of administering the sedative and monitoring the patient. Various scoring systems exist for defining the discharge criteria, of which the Aldrete score is the most commonly used.
- 1 April 2019
- Published by Georg Thieme Verlag KG in Journal of Digestive Endoscopy
- Vol. 10 (2) , 97-100
Open AccessSedation and Anesthesia in Gastrointestinal Endoscopy: Indian Scenario
Sedation in endoscopy is a drug-induced depression in the level of consciousness. Traditionally, the sedation regime most commonly used for conscious sedation during gastrointestinal (GI) endoscopy was a combination of opioids and benzodiazepines. However, in the last two decades, propofol is regarded as the sine qua non agent for gastroenterological endoscopic sedation. A thorough risk evaluation before the procedure and monitoring during the procedure are paramount. In elective endoscopy, unplanned adverse events are rare, occurring in 1.4% of procedures. All currently available guidelines state that the endoscopist is not permitted to administer propofol and to monitor the patient. This task must be done by an additional person, who has the sole responsibility of administering the sedative and monitoring the patient. Various scoring systems exist for defining the discharge criteria, of which the Aldrete score is the most commonly used.
- Open Access
- 1 April 2018
- Published by Georg Thieme Verlag KG in Journal of Digestive Endoscopy
- Vol. 9 (2) , 77-79
Large Amoebic Liver Abscess with Persistent Biliary Fistula
Liver abscess with biliary communication poses management problem if percutaneous drainage is performed. We report a case of large amoebic liver abscess (ALA) with jaundice. Prolonged high-output bile drainage after percutaneous drainage of ALA showed suspicion of communication of abscess with intrahepatic bile ducts (biliary fistula). The same was managed successfully with endoscopic biliary stent placement with medical management.
- 1 April 2018
- Published by Georg Thieme Verlag KG in Journal of Digestive Endoscopy
- Vol. 9 (2) , 77-79
Open AccessLarge Amoebic Liver Abscess with Persistent Biliary Fistula
Liver abscess with biliary communication poses management problem if percutaneous drainage is performed. We report a case of large amoebic liver abscess (ALA) with jaundice. Prolonged high-output bile drainage after percutaneous drainage of ALA showed suspicion of communication of abscess with intrahepatic bile ducts (biliary fistula). The same was managed successfully with endoscopic biliary stent placement with medical management.
- 1 March 2018
- Published by Elsevier in Journal of Clinical and Experimental Hepatology
- Vol. 8 (1) , 50-57
Natural History of Cirrhosis of Liver after First Decompensation: A Prospective Study in India
- 1 March 2018
- Published by Elsevier in Journal of Clinical and Experimental Hepatology
- Vol. 8 (1) , 50-57
Natural History of Cirrhosis of Liver after First Decompensation: A Prospective Study in India
- 5 July 2017
- Published by Wiley in Liver International
- Vol. 38 (1) , 23-32
Spectrum of hepatitis B and renal involvement
Renal involvement in hepatitis B occurs in various spectrums and its knowledge is important for clinicians in management of patients. The renal diseases most commonly associated with hepatitis B virus (HBV) infection include membranous nephropathy, membranoproliferative glomerulonephritis and Polyarteritis nodosa. The widespread use of hepatitis B vaccination has decreased the incidence of HBV‐related renal diseases. The incidence of HBV infection in dialysis patients has significantly decreased over the past few decades because of screening of blood products for hepatitis B surface antigen (HBsAg) and hepatitis B core antibody, implementation of infection control measures and hepatitis B vaccination. The definition of acute kidney injury has been recently modified in cirrhotic population, helping in prognosis and prediction of mortality. The most common etiologies of acute kidney injury in this cirrhotic population, which account for 80% to 90% of all cases, include volume depletion, acute tubular necrosis and hepatorenal syndrome. Treatment with oral nucleoside/tide analogues (NA) brought a new paradigm in the management of HBsAg positive glomerulonephritis, kidney transplant recipients and dialysis patients, resulting in effective viral suppression, reduced hepatic complications and improved patient survival, without compromising renal allograft outcome. NAs are cleared by the kidneys and therefore their dosage has to be adjusted in all patients with impaired renal function. This article reviews the recent knowledge of the pathogenesis and treatment of HBV‐related glomerulonephritis and discusses the management of hepatitis B in patients on dialysis, kidney transplant recipients and cirrhotics, which is continuously evolving.
- 5 July 2017
- Published by Wiley in Liver International
- Vol. 38 (1) , 23-32
Spectrum of hepatitis B and renal involvement
Renal involvement in hepatitis B occurs in various spectrums and its knowledge is important for clinicians in management of patients. The renal diseases most commonly associated with hepatitis B virus (HBV) infection include membranous nephropathy, membranoproliferative glomerulonephritis and Polyarteritis nodosa. The widespread use of hepatitis B vaccination has decreased the incidence of HBV‐related renal diseases. The incidence of HBV infection in dialysis patients has significantly decreased over the past few decades because of screening of blood products for hepatitis B surface antigen (HBsAg) and hepatitis B core antibody, implementation of infection control measures and hepatitis B vaccination. The definition of acute kidney injury has been recently modified in cirrhotic population, helping in prognosis and prediction of mortality. The most common etiologies of acute kidney injury in this cirrhotic population, which account for 80% to 90% of all cases, include volume depletion, acute tubular necrosis and hepatorenal syndrome. Treatment with oral nucleoside/tide analogues (NA) brought a new paradigm in the management of HBsAg positive glomerulonephritis, kidney transplant recipients and dialysis patients, resulting in effective viral suppression, reduced hepatic complications and improved patient survival, without compromising renal allograft outcome. NAs are cleared by the kidneys and therefore their dosage has to be adjusted in all patients with impaired renal function. This article reviews the recent knowledge of the pathogenesis and treatment of HBV‐related glomerulonephritis and discusses the management of hepatitis B in patients on dialysis, kidney transplant recipients and cirrhotics, which is continuously evolving.
- 1 July 2017
- Published by Elsevier in Journal of Clinical and Experimental Hepatology
- Vol. 7, S110
Endoscopic Biliary Drainage in an Amoebic Liver Abscess (ALA) With Persistent Biliary Communication
- 1 July 2017
- Published by Elsevier in Journal of Clinical and Experimental Hepatology
- Vol. 7, S110
Endoscopic Biliary Drainage in an Amoebic Liver Abscess (ALA) With Persistent Biliary Communication
- 1 July 2017
- Published by Elsevier in Journal of Clinical and Experimental Hepatology
- Vol. 7, S50-S51
Chronic Autoimmune Hepatitis With Chronic Ulcerative Colitis in a Young Boy—A Rare Entity
- 1 July 2017
- Published by Elsevier in Journal of Clinical and Experimental Hepatology
- Vol. 7, S50-S51
Chronic Autoimmune Hepatitis With Chronic Ulcerative Colitis in a Young Boy—A Rare Entity
- 20 October 2016
- Published by Wolters Kluwer Health in Hepatology
- Vol. 65 (2) , 751-752
Do we need to correct coagulation abnormalities prophylactically in patients with cirrhosis undergoing invasive procedures? a dilemma
- 20 October 2016
- Published by Wolters Kluwer Health in Hepatology
- Vol. 65 (2) , 751-752
Do we need to correct coagulation abnormalities prophylactically in patients with cirrhosis undergoing invasive procedures? a dilemma